(Q64170782)

English

Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A MULTICENTER, PHASE 1B, OPEN-LABEL STUDY TO DETERMINE THE SAFETY AND ACTIVITY OF CC-292 IN COMBINATION WITH LENALIDOMIDE IN SUBJECTS WITH RELAPSED AND/OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA / SMALL LYMPHOCYTIC LYMPHOMA (English)

0 references

0 references

0 references

United States of America

0 references

start time

28 December 2012

0 references

end time

23 January 2019

0 references

number of participants

20

0 references

research intervention

(RS)-lenalidomide

0 references

clinical trial phase

phase I clinical trial

0 references

research site

Icahn School of Medicine at Mount Sinai

0 references

University of Tennessee, Knoxville

0 references

minimum age

18 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT01732861

0 references

(Q64170782)

Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)